
Arthur J. Gallagher & Co. (AJG), a large-cap insurance firm, received a 56% rating from Validea's Buffett-inspired Patient Investor model, indicating a lack of strong interest from this fundamental perspective. While AJG passed tests for earnings predictability, free cash flow, and retained earnings use, it failed on critical metrics like return on equity and expected return, falling short of the 80% threshold typically signaling significant alignment with the strategy.
Arthur J. Gallagher & Co. (AJG) garners a mediocre 56% rating based on Validea's Patient Investor model, which emulates the strategy of Warren Buffett. This score falls significantly below the 80% threshold that would typically indicate strategic interest, reflecting a mixed fundamental picture. The company demonstrates strengths in operational stability, passing criteria for earnings predictability, return on assets, free cash flow generation, and the effective use of retained earnings. However, from a value investment perspective, critical weaknesses emerge. AJG fails on key profitability and valuation tests, specifically Return on Equity (ROE), Initial Rate of Return, and Expected Return. The neutral rating on share repurchases indicates its capital return policy is not a significant factor in the model's assessment. The resulting slightly negative sentiment score of -0.2 for AJG underscores that while the business appears durable, its current valuation and profitability profile do not align with the stringent requirements of this particular deep-value investment framework.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment